Report cover image

Global Esomeprazole Magnesium Enteric-coated Tablets Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 199 Pages
SKU # APRC20278801

Description

Summary

According to APO Research, the global Esomeprazole Magnesium Enteric-coated Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Esomeprazole Magnesium Enteric-coated Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Esomeprazole Magnesium Enteric-coated Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Esomeprazole Magnesium Enteric-coated Tablets market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Esomeprazole Magnesium Enteric-coated Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Esomeprazole Magnesium Enteric-coated Tablets market include Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, AstraZeneca, China Resources Sanjiu Medical & Pharmaceutical, Pfizer Inc., Merck and Novartis Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Esomeprazole Magnesium Enteric-coated Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Esomeprazole Magnesium Enteric-coated Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Esomeprazole Magnesium Enteric-coated Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Esomeprazole Magnesium Enteric-coated Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Esomeprazole Magnesium Enteric-coated Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Esomeprazole Magnesium Enteric-coated Tablets sales, projected growth trends, production technology, application and end-user industry.


Esomeprazole Magnesium Enteric-coated Tablets Segment by Company


Dr. Reddy's Laboratories

Sun Pharmaceutical Industries

AstraZeneca

China Resources Sanjiu Medical & Pharmaceutical

Pfizer Inc.

Merck

Novartis Pharmaceuticals

Esomeprazole Magnesium Enteric-coated Tablets Segment by Type


20mg

40mg

Esomeprazole Magnesium Enteric-coated Tablets Segment by Application


Clinic

Hospital

Others

Esomeprazole Magnesium Enteric-coated Tablets Segment by Region


North America


United States

Canada

Mexico

Europe


Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific


China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America


Brazil

Argentina

Chile

Middle East & Africa


Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Esomeprazole Magnesium Enteric-coated Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Esomeprazole Magnesium Enteric-coated Tablets market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Esomeprazole Magnesium Enteric-coated Tablets significant trends, drivers, influence factors in global and regions.
6. To analyze Esomeprazole Magnesium Enteric-coated Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esomeprazole Magnesium Enteric-coated Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Esomeprazole Magnesium Enteric-coated Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esomeprazole Magnesium Enteric-coated Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Esomeprazole Magnesium Enteric-coated Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Esomeprazole Magnesium Enteric-coated Tablets industry.
Chapter 3: Detailed analysis of Esomeprazole Magnesium Enteric-coated Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Esomeprazole Magnesium Enteric-coated Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Esomeprazole Magnesium Enteric-coated Tablets in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value (2020-2031)
1.2.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Volume (2020-2031)
1.2.3 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Esomeprazole Magnesium Enteric-coated Tablets Market Dynamics
2.1 Esomeprazole Magnesium Enteric-coated Tablets Industry Trends
2.2 Esomeprazole Magnesium Enteric-coated Tablets Industry Drivers
2.3 Esomeprazole Magnesium Enteric-coated Tablets Industry Opportunities and Challenges
2.4 Esomeprazole Magnesium Enteric-coated Tablets Industry Restraints
3 Esomeprazole Magnesium Enteric-coated Tablets Market by Company
3.1 Global Esomeprazole Magnesium Enteric-coated Tablets Company Revenue Ranking in 2024
3.2 Global Esomeprazole Magnesium Enteric-coated Tablets Revenue by Company (2020-2025)
3.3 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Volume by Company (2020-2025)
3.4 Global Esomeprazole Magnesium Enteric-coated Tablets Average Price by Company (2020-2025)
3.5 Global Esomeprazole Magnesium Enteric-coated Tablets Company Ranking (2023-2025)
3.6 Global Esomeprazole Magnesium Enteric-coated Tablets Company Manufacturing Base and Headquarters
3.7 Global Esomeprazole Magnesium Enteric-coated Tablets Company Product Type and Application
3.8 Global Esomeprazole Magnesium Enteric-coated Tablets Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Esomeprazole Magnesium Enteric-coated Tablets Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Esomeprazole Magnesium Enteric-coated Tablets Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Esomeprazole Magnesium Enteric-coated Tablets Market by Type
4.1 Esomeprazole Magnesium Enteric-coated Tablets Type Introduction
4.1.1 20mg
4.1.2 40mg
4.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Volume by Type
4.2.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Volume by Type (2020-2031)
4.2.3 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Volume Share by Type (2020-2031)
4.3 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Type
4.3.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Type (2020-2031)
4.3.3 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type (2020-2031)
5 Esomeprazole Magnesium Enteric-coated Tablets Market by Application
5.1 Esomeprazole Magnesium Enteric-coated Tablets Application Introduction
5.1.1 Clinic
5.1.2 Hospital
5.1.3 Others
5.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Volume by Application
5.2.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Volume by Application (2020-2031)
5.2.3 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Volume Share by Application (2020-2031)
5.3 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Application
5.3.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Application (2020-2031)
5.3.3 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application (2020-2031)
6 Esomeprazole Magnesium Enteric-coated Tablets Regional Sales and Value Analysis
6.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales by Region (2020-2031)
6.2.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales by Region: 2020-2025
6.2.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales by Region (2026-2031)
6.3 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Region (2020-2031)
6.4.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Region: 2020-2025
6.4.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Region (2026-2031)
6.5 Global Esomeprazole Magnesium Enteric-coated Tablets Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Esomeprazole Magnesium Enteric-coated Tablets Sales Value (2020-2031)
6.6.2 North America Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Esomeprazole Magnesium Enteric-coated Tablets Sales Value (2020-2031)
6.7.2 Europe Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Sales Value (2020-2031)
6.8.2 Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Esomeprazole Magnesium Enteric-coated Tablets Sales Value (2020-2031)
6.9.2 South America Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Esomeprazole Magnesium Enteric-coated Tablets Sales Value (2020-2031)
6.10.2 Middle East & Africa Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Country, 2024 VS 2031
7 Esomeprazole Magnesium Enteric-coated Tablets Country-level Sales and Value Analysis
7.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Esomeprazole Magnesium Enteric-coated Tablets Sales by Country (2020-2031)
7.3.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales by Country (2020-2025)
7.3.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales by Country (2026-2031)
7.4 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Country (2020-2031)
7.4.1 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Country (2020-2025)
7.4.2 Global Esomeprazole Magnesium Enteric-coated Tablets Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.5.2 USA Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.6.2 Canada Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.8.2 Germany Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.9.2 France Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.9.3 France Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.11.2 Italy Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.12.2 Spain Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.13.2 Russia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.16.2 China Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.16.3 China Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.17.2 Japan Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.19.2 India Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.19.3 India Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.20.2 Australia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.24.2 Chile Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.26.2 Peru Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.28.2 Israel Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.29.2 UAE Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.31.2 Iran Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Esomeprazole Magnesium Enteric-coated Tablets Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Esomeprazole Magnesium Enteric-coated Tablets Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Dr. Reddy's Laboratories
8.1.1 Dr. Reddy's Laboratories Comapny Information
8.1.2 Dr. Reddy's Laboratories Business Overview
8.1.3 Dr. Reddy's Laboratories Esomeprazole Magnesium Enteric-coated Tablets Sales, Value and Gross Margin (2020-2025)
8.1.4 Dr. Reddy's Laboratories Esomeprazole Magnesium Enteric-coated Tablets Product Portfolio
8.1.5 Dr. Reddy's Laboratories Recent Developments
8.2 Sun Pharmaceutical Industries
8.2.1 Sun Pharmaceutical Industries Comapny Information
8.2.2 Sun Pharmaceutical Industries Business Overview
8.2.3 Sun Pharmaceutical Industries Esomeprazole Magnesium Enteric-coated Tablets Sales, Value and Gross Margin (2020-2025)
8.2.4 Sun Pharmaceutical Industries Esomeprazole Magnesium Enteric-coated Tablets Product Portfolio
8.2.5 Sun Pharmaceutical Industries Recent Developments
8.3 AstraZeneca
8.3.1 AstraZeneca Comapny Information
8.3.2 AstraZeneca Business Overview
8.3.3 AstraZeneca Esomeprazole Magnesium Enteric-coated Tablets Sales, Value and Gross Margin (2020-2025)
8.3.4 AstraZeneca Esomeprazole Magnesium Enteric-coated Tablets Product Portfolio
8.3.5 AstraZeneca Recent Developments
8.4 China Resources Sanjiu Medical & Pharmaceutical
8.4.1 China Resources Sanjiu Medical & Pharmaceutical Comapny Information
8.4.2 China Resources Sanjiu Medical & Pharmaceutical Business Overview
8.4.3 China Resources Sanjiu Medical & Pharmaceutical Esomeprazole Magnesium Enteric-coated Tablets Sales, Value and Gross Margin (2020-2025)
8.4.4 China Resources Sanjiu Medical & Pharmaceutical Esomeprazole Magnesium Enteric-coated Tablets Product Portfolio
8.4.5 China Resources Sanjiu Medical & Pharmaceutical Recent Developments
8.5 Pfizer Inc.
8.5.1 Pfizer Inc. Comapny Information
8.5.2 Pfizer Inc. Business Overview
8.5.3 Pfizer Inc. Esomeprazole Magnesium Enteric-coated Tablets Sales, Value and Gross Margin (2020-2025)
8.5.4 Pfizer Inc. Esomeprazole Magnesium Enteric-coated Tablets Product Portfolio
8.5.5 Pfizer Inc. Recent Developments
8.6 Merck
8.6.1 Merck Comapny Information
8.6.2 Merck Business Overview
8.6.3 Merck Esomeprazole Magnesium Enteric-coated Tablets Sales, Value and Gross Margin (2020-2025)
8.6.4 Merck Esomeprazole Magnesium Enteric-coated Tablets Product Portfolio
8.6.5 Merck Recent Developments
8.7 Novartis Pharmaceuticals
8.7.1 Novartis Pharmaceuticals Comapny Information
8.7.2 Novartis Pharmaceuticals Business Overview
8.7.3 Novartis Pharmaceuticals Esomeprazole Magnesium Enteric-coated Tablets Sales, Value and Gross Margin (2020-2025)
8.7.4 Novartis Pharmaceuticals Esomeprazole Magnesium Enteric-coated Tablets Product Portfolio
8.7.5 Novartis Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Esomeprazole Magnesium Enteric-coated Tablets Value Chain Analysis
9.1.1 Esomeprazole Magnesium Enteric-coated Tablets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Esomeprazole Magnesium Enteric-coated Tablets Sales Mode & Process
9.2 Esomeprazole Magnesium Enteric-coated Tablets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Esomeprazole Magnesium Enteric-coated Tablets Distributors
9.2.3 Esomeprazole Magnesium Enteric-coated Tablets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.